-
PHONE: 1-866-918-6812
LV-CAG-tdTOMATO
Product Category: Pre-made Recombinant Lentivirus | LV-CAG-tdTOMATO | LV-CBA-tdTOMATO | CAG-tdTOMATO Lentivirus
Description:
LV-CAG-tdTOMATO is a pre-made recombinant lentiviral vector designed for robust and stable expression of the red fluorescent reporter protein tdTomato under the control of the CAG promoter (also known as the CBA promoter). The CAG promoter combines the cytomegalovirus (CMV) immediate-early enhancer with the chicken β-actin promoter, enabling strong and constitutive transgene expression across a broad range of mammalian cell types.
tdTomato is a bright red fluorescent protein with excellent photostability and high quantum yield, making it well suited for monitoring transduction efficiency, tracking cells, visualizing gene expression, and performing in vitro and in vivo imaging studies. Following transduction, the lentiviral vector integrates into the host cell genome, enabling long-term and stable expression of tdTomato in both dividing and non-dividing cells.
This ready-to-use lentiviral preparation is suitable for applications including cell labeling, lineage tracing, cell tracking, transduction optimization, fluorescence microscopy, flow cytometry, and the generation of stable fluorescent cell lines.
Titer: >1E+9 TU/mL
Selection Antibiotic: None
Purity*: In vivo grade and OK for both in vitro tissue culture infection and in vivo injection
Size: 2 x 25 µL (Std Pack)
Storage Buffer: PBS
Infection Protocol: 
Transfer Vector Map:
* Concentrated via PEG precipitation followed by ultra-centrifugation at 25000 rpm
CITATIONS
| Shipping Weight | 6 lbs |
|---|---|
| Unit Size | 2 x 25 µL at >10⁹ TU/mL, 25 µL at >10⁹ TU/mL |
Customers who bought this product also purchased…
- SL100349LV-EF1a-Mito-DsRed-IRES-Puro$468.00Add to cart This product has multiple variants. The options may be chosen on the product page
Custom Service Solutions
Looking for a customized solution? Our end-to-end capabilities support both in vitro and in vivo applications, with rigorous quality control, scalable production processes, and expert scientific oversight at every stage.
Important updates waiting for you!
Enter your email address below and subscribe to our newsletter